SU1045450A1 - Method of determining coagulation time - Google Patents
Method of determining coagulation time Download PDFInfo
- Publication number
- SU1045450A1 SU1045450A1 SU813345866A SU3345866A SU1045450A1 SU 1045450 A1 SU1045450 A1 SU 1045450A1 SU 813345866 A SU813345866 A SU 813345866A SU 3345866 A SU3345866 A SU 3345866A SU 1045450 A1 SU1045450 A1 SU 1045450A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- blood
- determining
- time
- kaolin
- coagulation time
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
СПОСОБ ОПРЕДЕЛЕНИЯ ВРЕЖНИ СВЕРТЫВАНИЯ КРОВИ путчем гжтивации свертывающей систеш крови каолином с последующим определением времени образовани сгустков фибрина, о тличающий с тем, что, с целью ускорени и повышешш точности способа , цельную кровь добавл ют к сухому порошкообразному каолину в конечной концентрации 0,5fO,01%.METHOD FOR DETERMINING THE BLOOD COLLECTION OF THE BLOOD Patching the coagulation of the blood coagulation with kaolin followed by determining the time of formation of fibrin clots, which means that, in order to accelerate and improve the accuracy of the method, whole blood is added to the dry powder of kaolin at a final concentration of 0.5 ffos in the final concentration of 0.5 f i. %
Description
Изобретение относитс к медихшне, . а именно к способам оцределени биохимических параметров крови пациента во врем оперативного вмешательства с искусственным кровообращением.This invention relates to copper,. in particular, methods for determining the biochemical parameters of a patient’s blood during surgery with artificial blood circulation.
Известен способ определени времени свертывани крови, преимущественно при операци х с искусственным кровообращением , при котором временно создают гипокоагул цию крови тепарином . В этом случае, воздейству на цельную кровь .диатомной (инфузорной) земпей, определ ют активированное . врем ее свертывани и суд т о содержakии гепарина в крови по установленной мекду ними дл данного пациента линейной зависимости.There is a known method for determining the blood coagulation time, mainly during operations with artificial blood circulation, at which blood is temporarily hypocoagulated with teparin. In this case, the effect on whole blood of the diatomic (infusorial) Zempei is determined to be activated. its clotting time is judged on the heparin content in the blood by the linear dependence established by them for the given patient.
Недостаток известного способа закпючаетс в том, что при высоком со- ; держании гепарина в крови (пор дка 3-5 мг/кг массы пациента), необходимом so врем искусственного кровообращени , промежуток времени между началом и окончанием процесса образовани фибринового сзтустка крови достаточно продолжителен и лишен четких границ. При проведении анализа с использованием диатомной земли, которую удаетс смааать с цельной кровью в сосуде только цри многократном переворачивании его на 180° j надежно ре- -гистрируютс шдаьсгустки в виде пленок и нитей фибрина, в процессе фор миро- .. вани которых трудно выделить /начальную точку.The disadvantage of this method is that in case of high co-; keeping heparin in the blood (on the order of 3-5 mg / kg of the patient's mass), required for the time of cardiopulmonary bypass, the time interval between the beginning and the end of the process of formation of fibrinous blood by the blood is sufficiently long and lacks clear boundaries. When analyzing with the use of diatomaceous earth, which can be smeared with whole blood in a vessel, only if it is inverted by 180 ° j multiple times, it is reliably re-registered in the form of fibrin films and filaments, which are difficult to isolate during the formation of starting point.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU813345866A SU1045450A1 (en) | 1981-07-06 | 1981-07-06 | Method of determining coagulation time |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU813345866A SU1045450A1 (en) | 1981-07-06 | 1981-07-06 | Method of determining coagulation time |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1045450A1 true SU1045450A1 (en) | 1991-02-07 |
Family
ID=20979635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU813345866A SU1045450A1 (en) | 1981-07-06 | 1981-07-06 | Method of determining coagulation time |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1045450A1 (en) |
-
1981
- 1981-07-06 SU SU813345866A patent/SU1045450A1/en active
Non-Patent Citations (1)
Title |
---|
Дементьева И.И. Использование активированного времени свертывани дан контрол за уровнем гепаринизакии при операци х с искусственным кровообращением. - Анестезиологи и реанимаци , 1980, № 4, с. 29-3. Гольдберг Е.Д. , Драмарецка М.К. Характеристика функционального состо ни гемостаза здоровых взрослых людей. - Лаб. дело, 1978, № 10, с..589-590. s--irnnp llia SJ;jSv°JiW-:. :-йПМ1;:ШНШШ ..:-. It ikf- 1 ЕИА * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rabiner et al. | The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure | |
Lever et al. | Renin and angiotensin-like activity in renal lymph | |
US3955925A (en) | Preparation of optically clear serum | |
CA1101768A (en) | Method and device for treatment of blood | |
ATE238078T1 (en) | METHOD FOR PRODUCING A TISSUE ADHESIVE WHICH IS COAGULATED BY ADDING CALCIUM IONS | |
RU95113187A (en) | METHOD FOR DETERMINING SYSTEM INFLAMMATION | |
ATE426677T1 (en) | VESSEL FOR COLLECTION OF BLOOD | |
ATE11640T1 (en) | METHOD OF PREPARING BLOOD COAGULATION FACTORS. | |
NO178682C (en) | Method for Stabilizing Blood Coagulation Factors, as well as Control Plasma and Reagents to Determine Biological Activity of Blood Coagulation Factors | |
Gladner et al. | Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots | |
ATE141509T1 (en) | METHOD FOR STORING ERYTHROCYTES | |
DE3587177D1 (en) | METHOD FOR DETERMINING LOW AMOUNT OF SUBSTANCES OF MEDICINAL PRODUCTS, BODY'S OWN OR OTHER CHEMICAL SUBSTANCES IN BIOLOGICAL MATERIAL. | |
SU1045450A1 (en) | Method of determining coagulation time | |
FR2326705A1 (en) | METHOD OF DETERMINING THE ACTIVATION OF THE BLOOD COAGULATION SYSTEM OR OF THE FIBRINOLYTIC SYSTEM IN BLOOD PLASMA | |
US4795703A (en) | Heparin assay | |
RU2000123400A (en) | METHOD FOR REMOVING ETHIOLOGICAL FACTOR (FACTORS) OF TRANSMISSIVE SPAN Encephalopathies FROM PROTEIN SOLUTIONS | |
Murphy et al. | Endogenous anticoagulation during extracorporeal perfusion: generation of a heparinlike inhibitor | |
US4423036A (en) | Acid soluble platelet aggregating material isolated from human umbilical cord | |
De Bosch et al. | An abnormal fibrinogen in a Venezuelan family | |
Wikner et al. | [20] Chemotactic fragments of fibronectin | |
SU1391652A1 (en) | Method of increasing thromboresistance of polymeric materials | |
SU1737335A1 (en) | Method of determining intravascular blood coagulation | |
DK0587090T3 (en) | Method for determining thrombosis-causing lupus anticoagulant antibodies. | |
ATE184107T1 (en) | METHOD AND COMPOSITION FOR LYSING ERYTHROCYTES, BLOOD COMPOSITIONS AND METHOD FOR LEUKOCYTE ANALYSIS | |
SU1170318A1 (en) | Method of determining blood capillaries on histologic specimen |